Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study

01.10.2017 | Rufino Silva MD, PhD, András Berta MD, PhD, Michael Larsen MD, DMSc, Wayne Macfadden MD, Chrystel Feller PhD and Jordi Monés MD, PhD

Ophthalmology, 2018-01-01, Volume 125, Issue 1, Pages 57-65, Copyright © 2017 American Academy of Ophthalmology

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)

28.09.2017 | Michael F. Marmor, MD, Ulrich Kellner, MD, Timothy Y.Y. Lai, MD, FRCOphth,∙ Ronald B. Melles, MD, William F. Mieler, MD for the American Academy of Ophthalmology

Ophthalmology 2016, 123 (6): 1386-94

Aflibercept After Ranibizumab Intravitreal Injections in Exudative Age–Related Macular Degeneration: The Ari2 Study

01.01.2017 | Blanco-Garavito, Rocio MD, Jung, Camille PhD, Uzzan, Joel MD, Quaranta-ElMaftouhi, Maddalena MD, Coscas, Florence MD, Sahel, Jose PhD, Korobelnik, Jean-Francois MD, Bechet, Stephane PhD, Querques, Giuseppe PhD, Souied, Eric H. PhD

Retina. 38(12):2285-2292, December 2018